AlloVir, Inc. Announces Appointment of Diana Brainard as Chief Executive Officer, Effective May 17, 2021
May 13, 2021 at 02:52 pm IST
AlloVir, Inc. announced appointment of Dr. Diana Brainard as Chief Executive Officer, effective May 17, 2021. Dr. Brainard is a physician-scientist specializing in infectious diseases, with more than 20 years of experience in the biopharmaceutical industry and academic medicine, most recently serving as Senior Vice President and Head of the Virology Therapeutic Area at Gilead Sciences.